Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

$ 26.50

4.5
(763)
In stock
Description

Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June

A catalog of curated breast cancer genes

William Oh on LinkedIn: Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for…

Breast cancer risk estimates from composite gene model in validation

Frontiers Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector

FDA Authorizes First Genetic Test to Assess Risk of Multiple Cancers

A Population-Based Study of Genes Previously Implicated in Breast Cancer

CHEK2 Carrier Modification with Polygenic Risk Score

PALB2 – Inherited Cancer Registry (ICARE)

BREAST CANCER PRS (Polygenic Risk Score) –

Interpreting Cancer Genetic Testing Results (CME)

/books/NBK65767/bin/CDR0000766